@MLJohnsonMD2 debating @charlesrudin at #TTLC2026 in SCLC Session. First-Line Future? Two great presentations. A lot of fun, but there can only be one winner (…MJ!…)
English
David R. Spigel, MD, FASCO
116 posts
David R. Spigel, MD, FASCO
@DavidRSpigel
President and Chief Medical Officer at Sarah Cannon Research Institute | Advancing Therapies Through Clinical Research #Oncology #Healthcare #CancerResearch
Nashville, TN Beigetreten Mart 2011
742 Folgt3.1K Follower
David R. Spigel, MD, FASCO retweetet
@SCRIOncology was honored to co-host the @AmericanCancer ACS gala in Nashville.
Amazing fundraising effort benefitting patients facing cancer.
@DavidRSpigel
@MLJohnsonMD2
@MeredithMcKean
@ErikaHamilton9
@BGarmezy
@MeredithPelster
@SPremji7866
@SarahCannonDocs
English
David R. Spigel, MD, FASCO retweetet
🎪 🤡 🐘 🦁
Happy Halloween from the circus!
@MLJohnsonMD2 @DavidRSpigel @VivekSubbiah @BurrisSkip @SarahCannonDocs
English
David R. Spigel, MD, FASCO retweetet
🚨🚀Pleased to shared with the Universe 👉HOT OFF THE PRESS👉Simultaneously published with the NEW #ESMO25 @myESMO Tumour Agnostic Tack👉 "Rethinking Cancer Drug Development through Tumor-Agnostic Precision Medicine" @AACR journal @CD_AACR @OncoAlert 👉 Read this paper that will be presented at the special session at ESMO
aacrjournals.org/cancerdiscover…
English
David R. Spigel, MD, FASCO retweetet
📅 We're counting down until #ESMO25 kicks off in Berlin tomorrow!
🗨️ Don't miss this interview with @StephenVLiu, who discusses anticipated thoracic oncology highlights of the meeting!
➡️ Watch now: buff.ly/mqoXWoA
#lcsm #NSCLC #SCLC #ESMO2025 @myESMO
English
David R. Spigel, MD, FASCO retweetet
Honored to represent @ASCO and @SarahCannonDocs at the JSCO 2025 conference in Tokyo. We had an amazing conversation about ctDNA in perioperative oncology. I look forward to even more data coming at #ESMO25 #esmo2025
English
David R. Spigel, MD, FASCO retweetet
Dr. Hans Lee & Dr. Kris Patel from @SCRIoncology share how new therapies like CAR T-cell treatment are changing lives.
📺 Watch the full @NC5 segment here: youtube.com/watch?v=hg4_bw…
#BloodCancerAwareness #LymphomaAwareness #CancerCare #SCRI
YouTube
English
Congratulations!! Well deserved Stephen!
Stephen V Liu, MD@StephenVLiu
Honored and humbled to accept a new role as Division Chief for Hematology & Oncology at Georgetown starting next month. Excited for all that the future holds for @Georgetown @LombardiCancer with the best colleagues one could ask for.
English
David R. Spigel, MD, FASCO retweetet
NEW in @OncogeneJournal: @MiNK_iNKT reports complete remission in metastatic, SOC + ICI-refractory testicular cancer with allo-iNKT (agenT-797)
✔️ Durable survival
✔️ No lymphodepletion
✔️ No GVHD
🔗 Builds on 2L gastric PFS + >12mo OS
@Nature nature.com/articles/s4138…
English
David R. Spigel, MD, FASCO retweetet
Excited to share a story about the power of clinical trials! Please see our article on oncogene examining a robust and durable response with iNKT cell therapy in a patient with very refractory germ cell tumor.
@SarahCannonDocs and @SCRIOncology
nature.com/articles/s4138…
English
Dr. Joyce O’Shaughnessy delivering perfect update in advanced breast cancer research at #MLSNashville #ASCO25 meeting @SarahCannonDocs
English
English
David R. Spigel, MD, FASCO retweetet
Happening now at #ASCO25! Dr. Naqash serves as chair during the Oral Abstract Session: Lung Cancer-Non-
Small Cell Local-Regional/ Small Cell/ Other Thoracic Cancers session.
English
David R. Spigel, MD, FASCO retweetet
Happy to present Stellar-002 phase 1b study with zanzalitinib (tki) + nivo or
Nivo/rela. Add to the front line RCC data presented by @JadChahoud. Compelling activity and durability in a pre treated population! #ASCO25 @SarahCannonDocs lots of hard work and thanks to the patients!
English
David R. Spigel, MD, FASCO retweetet
Shout out to @ErikaHamilton9 for making sure to pronounce the names of all the speakers in #ASCO25 Plenary Session correctly (and not just the easy ones like “Mark Lewis” @marklewismd😊).
It’s a small thing, but shows respect when you care enough to do it right.
English
David R. Spigel, MD, FASCO retweetet
#ASCO25 🆒study acting on molecular progression noted on #ctDNA🩸🧬 ahead of radiographic disease progression - herein this was in patients with breast cancer.
💡Good utility of liquid biopsies if you have an actionable marker➕effective drugs.
📍Plenary session.
@OncoAlert
English
Amazing data! Congratulations! Impactful today!!#ASCO25
ASCO@ASCO
1st Plenary #ASCO25: #ATOMIC Ph III, adj mFOLFOX + Atezolizumab vs. mFOLFOX in Stg III dMMR colon ca. - 3yr DFS 86.4% vs 76.6% (HR 0.50), benefit seen in all subgroups. DFS 100% in Niche2 - ⬆️ discontinuation w/ Atezo - OS not mature - ⬆️ Gr4 neutropenia - To Adj or to NeoAdj?
English
SCRI is proud to contribute to the bold science and deep collaboration on display at #ASCO25. Our team is advancing clinical research brings hope to patients and loved ones everywhere. Explore our prescence: scri.com/asco/
@DavidRSpigel
English
David R. Spigel, MD, FASCO retweetet
David R. Spigel, MD, FASCO retweetet
So proud of this Star 🌟!
You're going to be seeing more of Dr. Sarah Premji #bcsm community!
#ASCO25 @SPremji7866 @Dee_Anna_Smith @DavidRSpigel @SCRIOncology @SarahCannonDocs
English